JMIR Res Protoc
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys.
Touloumi G, Karakosta A, Sypsa V, Petraki I, Anagnostou O, Terzidis A, Voudouri NM, Gavana M, Vantarakis A, Rachiotis G, Kantzanou M, Rosenberg T, Papatheodoridis G, Hatzakis A
Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or ...
Read More
Source: PubMed
Indian J Med Microbiol
Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression.
Mani M, Vijayaraghavan S, Sarangan G, Barani R, Abraham P, Srikanth P
Hepatitis B virus (HBV) is the most common aetiological factor causing hepatocellular carcinoma (HCC). HBx gene plays an enigmatic role in HBV-related ...
Read More
Source: PubMed
Sci Rep
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV.
Chen J, Xu Q, Zhang Y, Zhang H
Hepatitis B virus (HBV) is the main causative viral agent for liver diseases in China. In liver injury, exosomes may impede the interaction with chrom ...
Read More
Source: PubMed
J. Viral Hepat. 2020 Jan 30
A same day "test and treat" model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
Shiha G, Soliman R, Serwah A, Mikhail NN, Asselah T, Easterbrook P
Prompt access to confirmatory viral load testing and staging of liver disease are key barriers in uptake of treatment for chronic hepatitis B and C in ...
Read More
Source: PubMed
Mayo Clin Proc Innov Qual Outcomes
Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Bischin AM, Vishnu P, Chen R, Knopf KB, Aboulafia DM
To assess our adherence to treatment guidelines for diffuse large B-cell lymphoma (DLBCL) established by the American Society of Hematology in 2014 th ...
Read More
Source: PubMed
JMIR Res Protoc
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys.
Touloumi G, Karakosta A, Sypsa V, Petraki I, Anagnostou O, Terzidis A, Voudouri NM, Gavana M, Vantarakis A, Rachiotis G, Kantzanou M, Rosenberg T, Papatheodoridis G, Hatzakis A
Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or ...
Read More
Source: PubMed
Indian J Med Microbiol
Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression.
Mani M, Vijayaraghavan S, Sarangan G, Barani R, Abraham P, Srikanth P
Hepatitis B virus (HBV) is the most common aetiological factor causing hepatocellular carcinoma (HCC). HBx gene plays an enigmatic role in HBV-related ...
Read More
Source: PubMed
Sci Rep
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV.
Chen J, Xu Q, Zhang Y, Zhang H
Hepatitis B virus (HBV) is the main causative viral agent for liver diseases in China. In liver injury, exosomes may impede the interaction with chrom ...
Read More
Source: PubMed
J. Viral Hepat. 2020 Jan 30
A same day "test and treat" model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
Shiha G, Soliman R, Serwah A, Mikhail NN, Asselah T, Easterbrook P
Prompt access to confirmatory viral load testing and staging of liver disease are key barriers in uptake of treatment for chronic hepatitis B and C in ...
Read More
Source: PubMed
Mayo Clin Proc Innov Qual Outcomes
Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Bischin AM, Vishnu P, Chen R, Knopf KB, Aboulafia DM
To assess our adherence to treatment guidelines for diffuse large B-cell lymphoma (DLBCL) established by the American Society of Hematology in 2014 th ...
Read More
Source: PubMed
JMIR Res Protoc
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys.
Touloumi G, Karakosta A, Sypsa V, Petraki I, Anagnostou O, Terzidis A, Voudouri NM, Gavana M, Vantarakis A, Rachiotis G, Kantzanou M, Rosenberg T, Papatheodoridis G, Hatzakis A
Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or ...
Read More
Source: PubMed
Indian J Med Microbiol
Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression.
Mani M, Vijayaraghavan S, Sarangan G, Barani R, Abraham P, Srikanth P
Hepatitis B virus (HBV) is the most common aetiological factor causing hepatocellular carcinoma (HCC). HBx gene plays an enigmatic role in HBV-related ...
Read More
Source: PubMed
Sci Rep
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV.
Chen J, Xu Q, Zhang Y, Zhang H
Hepatitis B virus (HBV) is the main causative viral agent for liver diseases in China. In liver injury, exosomes may impede the interaction with chrom ...
Read More
Source: PubMed
J. Viral Hepat. 2020 Jan 30
A same day "test and treat" model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
Shiha G, Soliman R, Serwah A, Mikhail NN, Asselah T, Easterbrook P
Prompt access to confirmatory viral load testing and staging of liver disease are key barriers in uptake of treatment for chronic hepatitis B and C in ...
Read More
Source: PubMed
Mayo Clin Proc Innov Qual Outcomes
Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Bischin AM, Vishnu P, Chen R, Knopf KB, Aboulafia DM
To assess our adherence to treatment guidelines for diffuse large B-cell lymphoma (DLBCL) established by the American Society of Hematology in 2014 th ...
Read More
Source: PubMed
JMIR Res Protoc
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys.
Touloumi G, Karakosta A, Sypsa V, Petraki I, Anagnostou O, Terzidis A, Voudouri NM, Gavana M, Vantarakis A, Rachiotis G, Kantzanou M, Rosenberg T, Papatheodoridis G, Hatzakis A
Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or ...
Read More
Source: PubMed
Indian J Med Microbiol
Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression.
Mani M, Vijayaraghavan S, Sarangan G, Barani R, Abraham P, Srikanth P
Hepatitis B virus (HBV) is the most common aetiological factor causing hepatocellular carcinoma (HCC). HBx gene plays an enigmatic role in HBV-related ...
Read More
Source: PubMed
Sci Rep
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV.
Chen J, Xu Q, Zhang Y, Zhang H
Hepatitis B virus (HBV) is the main causative viral agent for liver diseases in China. In liver injury, exosomes may impede the interaction with chrom ...
Read More
Source: PubMed
J. Viral Hepat. 2020 Jan 30
A same day "test and treat" model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
Shiha G, Soliman R, Serwah A, Mikhail NN, Asselah T, Easterbrook P
Prompt access to confirmatory viral load testing and staging of liver disease are key barriers in uptake of treatment for chronic hepatitis B and C in ...
Read More
Source: PubMed
Mayo Clin Proc Innov Qual Outcomes
Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Bischin AM, Vishnu P, Chen R, Knopf KB, Aboulafia DM
To assess our adherence to treatment guidelines for diffuse large B-cell lymphoma (DLBCL) established by the American Society of Hematology in 2014 th ...
Read More
Source: PubMed
